Achieving an Aids Transition: Preventing Infections to Sustain Treatment

Achieving an Aids Transition: Preventing Infections to Sustain TreatmentAuthor: Mead Over
Publisher: Centre for Global Development
Category: Development Studies, Development Studies, Business Strategy, Public Health & Preventive Medicine, HIV / AIDS
Age Group: 15+
Book Format: Paperback

Five million people in poor countries are receiving AIDS treatment, but international AIDS policy is still in crisis. Donors are giving less than they had been, even though infections continue unabated, and the number of people dependent on treatment rises each year. This book proposes a feasible medium-term objective for AIDS policy: achieving an AIDS transition, that is, keeping AIDS deaths down by sustaining treatment while pushing new infections even lower, so that the total number of people living with HIV/AIDS begins to decline. How? Through a new, incentive-driven strategy to improve HIV prevention and a sustained effort to get the most from AIDS treatment.

Table Of ContentsThe Dynamics of an AIDS TransitionA" 1. Is there a population explosion of AIDS patients? 2. Recognition of existing incentives linking treatment and prevention 3. Overview of the book and its policy recommendations Sustaining AIDS Mortality Reductions 4. AIDS treatment successes 5. Neglected policies to sustain mortality reductions 6. AIDS treatment as the first international entitlement and its future fiscal burden 7. The likelihood and consequences of insufficient funding to treat all who need it Assuring HIV Prevention 8. HIV prevention successes 9. Neglected HIV prevention policies 10. Spillover effects of AIDS treatment 11. A cash-on-delivery approach to HIV prevention Reinforcing the Incentives to Achieve the HIV transition 12. Shifting the entitlement burden 13. Leveraging treatment demand for HIV prevention 14. The AIDS transition initiative
About Mead OverMead Over, a senior fellow at the Center for Global Development, is one of the world's leading experts on the economics and cost-effectiveness of HIV/AIDS prevention and treatment.